Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ELX-02 by Eloxx Pharmaceuticals for Alport Syndrome: Likelihood of Approval
ELX-02 is under clinical development by Eloxx Pharmaceuticals and currently in Phase II for Alport Syndrome. According to GlobalData, Phase...